News

Vitamin C could be up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG.

In a competition between two apparently equivalent proteins, one protein wins out every time as it swoops in to claim a cellular binding target.

Dana-Faber Cancer Institute report class IIa HDAC inhibitor, TMP195, switches the macrophage response by altering gene activity. Combining its effect with other immunotherapies significantly improved remission of breast cancer in a mouse model.

A protein has been found to have a previously unknown role in the ageing of cells. Researchers hope that the findings could one day lead to new treatments for ageing and early cancer.

A new technique has been recently developed that effectively identifies cancer-causing substances in the urine or blood.

Partnership aims to identify non-invasive VOC biomarkers in development of live biotherapeutics for disease diagnosis and patient stratification.

Researchers discovered that the activity of a number of genes are altered in the nasal cells of patients with lung cancer who have been smokers.

Consuming foods rich in isoflavones, found in soy, is associated with reduced mortality in women with hormone-receptor-negative breast cancer and women not treated with endocrine therapy

After four generations of development, a team has created a beta prototype of the Pocket Colposcope in collaboration with product design and development company 3rd Stone Design.

A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.